| Blueberry and CancerIn a 2005 study extracts were made of blueberry phenols, which 
were freeze dried and further separated into phenolic acids, tannins, flavanols 
and anthocyanins. The dried extracts were then added to cell cultures containing 
two colon cancer cell lines – HT 29 and Caco-2. In concentrations normally found 
in rat plasma after eating blueberries, anthocyanin fractions increased DNA 
fragmentation – a indication that apostosis had been triggered – by between 2 
and 7 times. Flavanol and tannin extracts cut cell proliferation time in half at 
concentrations of 70-100 and 50-100 microg/mL. The phenolic fraction reduced 
proliferation by a half at a concentration of 1000 microg/mL (Yi W, Fischer J, 
Krewer G, Akoh CC. Phenolic compounds from blueberries can inhibit colon cancer 
cell proliferation and induce apoptosis. J Agric Food Chem. 2005 Sep 
7;53(18):7320-9).   Blueberries contain another antioxidant compound called 
ellagic acid, which blocks metabolic pathways that can lead to cancer. A 
study involving 1,271 subjects, showed that those who ate the most strawberries 
(another food high in ellagic acid) were three times less likely to develop 
cancer than those who ate few or no strawberries (Hannum SM. Potential impact of 
strawberries on human health: a review of the science. Crit Rev Food Sci 
Nutr. 44, 1:1-17, 2004).Clinical AbstractsPhenolic compounds from blueberries can inhibit colon cancer 
cell proliferation and induce apoptosis.J Agric Food Chem. 2005 Sep 7;53(18):7320-9Department of Food Science and Technology, The University of 
Georgia, Athens, Georgia 30602-7610, USA.Research has shown that diets rich in phenolic compounds may be 
associated with lower risks of several chronic diseases including cancer. This 
study systematically evaluated the bioactivities of phenolic compounds in 
rabbiteye blueberries and assessed their potential antiproliferation and 
apoptosis induction effects using two colon cancer cell lines, HT-29 and Caco-2. 
Polyphenols in three blueberry cultivars, Briteblue, Tifblue, and Powderblue, 
were extracted and freeze-dried. The extracts were further separated into 
phenolic acids, tannins, flavonols, and anthocyanins using an HLB cartridge and 
LH20 column. Some individual phenolic acids and flavonoids were identified by 
HPLC with >90% purity in anthocyanin fractions. The dried extracts and 
fractions were added to the cell culture medium to test for antiproliferation 
activities and induction of apoptosis. Flavonol and tannin fractions resulted in 
50% inhibition of cell proliferation at concentrations of 70-100 and 50-100 
microg/mL in HT-29 and Caco-2 cells, respectively. The phenolic acid fraction 
showed relatively lower bioactivities with 50% inhibition at approximately 1000 
microg/mL. The greatest antiproliferation effect among all four fractions was 
from the anthocyanin fractions. Both HT-29 and Caco-2 cell growth was 
significantly inhibited by >50% by the anthocyanin fractions at 
concentrations of 15-50 microg/mL. Anthocyanin fractions also resulted in 2-7 
times increases in DNA fragmentation, indicating the induction of apoptosis. The 
effective dosage levels are close to the reported range of anthocyanin 
concentrations in rat plasma. These findings suggest that blueberry intake may 
reduce colon cancer risk.PMID: 16131149 [PubMed - indexed for MEDLINE]Blackberry, black raspberry, blueberry, cranberry, red 
raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of 
human cancer cells in vitro.J Agric Food Chem. 2006 Dec 13;54(25):9329-39Center for Human Nutrition, David Geffen School of Medicine, 
University of California, Los Angeles, CA 90095, USA. 
nseeram@mednet.ucla.eduBerry fruits are widely consumed in our diet and have attracted 
much attention due to their potential human health benefits. Berries contain a 
diverse range of phytochemicals with biological properties such as antioxidant, 
anticancer, anti-neurodegerative, and anti-inflammatory activities. In the 
current study, extracts of six popularly consumed berries--blackberry, black 
raspberry, blueberry, cranberry, red raspberry and strawberry--were evaluated 
for their phenolic constituents using high performance liquid chromatography 
with ultraviolet (HPLC-UV) and electrospray ionization mass spectrometry 
(LC-ESI-MS) detection. The major classes of berry phenolics were anthocyanins, 
flavonols, flavanols, ellagitannins, gallotannins, proanthocyanidins, and 
phenolic acids. The berry extracts were evaluated for their ability to inhibit 
the growth of human oral (KB, CAL-27), breast (MCF-7), colon (HT-29, HCT116), 
and prostate (LNCaP) tumor cell lines at concentrations ranging from 25 to 200 
micro g/mL. With increasing concentration of berry extract, increasing 
inhibition of cell proliferation in all of the cell lines were observed, with 
different degrees of potency between cell lines. The berry extracts were also 
evaluated for their ability to stimulate apoptosis of the COX-2 expressing colon 
cancer cell line, HT-29. Black raspberry and strawberry extracts showed the most 
significant pro-apoptotic effects against this cell line. The data provided by 
the current study and from other laboratories warrants further investigation 
into the chemopreventive and chemotherapeutic effects of berries using in vivo 
models.PMID: 17147415 [PubMed - in process]Absorption of anthocyanins from blueberry extracts by caco-2 
human intestinal cell monolayers.J Agric Food Chem. 2006 Jul 26;54(15):5651-8.   
Department of Food Science and Technology, The University of 
Georgia, Athens, Georgia 30602, USA.Recent studies have shown that dietary polyphenols may 
contribute to the prevention of cardiovascular disease and cancer. Anthocyanins 
from different plant sources including blueberries have been shown to possess 
potential anticancer activities. One of the key factors needed to correctly 
relate the in vitro study results to human disease outcomes is information about 
bioavailability. The objectives of the current study were to evaluate the 
absorption of blueberry anthocyanin extracts using Caco-2 human intestinal cell 
monolayers and investigate the effects of different aglycones, sugar moieties, 
and chemical structure on bioavailability of different types of anthocyanins. 
The results of this study showed that anthocyanins from blueberries could be 
transported through the Caco-2 cell monolayers although the transport/absorption 
efficiency was relatively low compared to other aglycone polyphenols. The 
transport efficiency of anthocyanins averaged approximately 3-4% [less than 1% 
in delphinidin glucoside (Dp-glc)]. No significant difference in 
transport/absorption efficiency was observed among three blueberry cultivars. 
The observed trends among different anthocyanins generally agreed well with some 
published in vivo results. Dp-glc showed the lowest transport/absorption 
efficiency, and malvidin glucoside (Mv-glc) showed the highest 
transport/absorption efficiency. Our result indicates that more free hydroxyl 
groups and less OCH(3) groups can decrease the bioavailability of anthocyanins. 
In addition, cyanindin glucoside (Cy-glc) showed significantly higher transport 
efficiency than cyanidin galactoside (Cy-gal), and peonidin glucoside (Pn-glc) 
showed significantly higher transport efficiency than peonidin galactoside 
(Pn-gal), indicating that glucose-based anthocyanins have higher bioavailability 
than galactose-based anthocyanins.PMID: 16848559 [PubMed - indexed for MEDLINE]
Differential effects of blueberry proanthocyanidins on 
androgen sensitive and insensitive human prostate cancer cell lines.Cancer Lett. 2006 Jan 18;231(2):240-6Department of Natural Resources and Environmental Sciences, 
University of Illinois at Urbana-Champaign, 1201 S. Dorner Dr, Urbana, IL 61801, 
USA.Blueberries are rich in health-promoting polyphenolic compounds 
including proanthocyanidins. The purpose of this study was to determine if 
proanthocyanidin-rich fractions from both wild and cultivated blueberry fruit 
have the same inhibitory effects on the proliferation of LNCaP, an 
androgen-sensitive prostate cancer cell line, and DU145, a more aggressive 
androgen insensitive prostate cancer cell line. When 20 microg/ml of a wild 
blueberry proanthocyanidin fraction (fraction 5) was added to LNCaP media, 
growth was inhibited to 11% of control with an IC50 of 13.3 microg/ml. Two 
similar proanthocyanidin-rich fractions from cultivated blueberries (fractions 4 
and 5) at the same concentration inhibited LNCaP growth to 57 and 26% of control 
with an IC50 of 22.7 and 5.8 microg/ml, respectively. In DU145 cells, the only 
fraction that significantly reduced growth compared to control was fraction 4 
from cultivated blueberries with an IC50 value of 74.4 microg/ml, indicating 
only minor inhibitory activity. Differences in cell growth inhibition of LNCaP 
and DU145 cell lines by blueberry fractions rich in proanthocyanidins indicate 
that blueberry proanthocyanidins have an effect primarily on androgen-dependant 
growth of prostate cancer cells. Possible molecular mechanisms for growth 
inhibition are reviewed.PMID: 16399225 [PubMed - indexed for MEDLINE]
Blueberry flavonoids inhibit matrix metalloproteinase 
activity in DU145 human prostate cancer cells.Biochem Cell Biol. 2005 Oct;83(5):637-43.Department of Biology, University of Prince Edward Island, 550 
UniversityAve., Charlottetown, PE C1A 4P3, Canada.Regulation of the matrix metalloproteinases (MMPs), the major 
mediators of extracellular matrix (ECM) degradation, is crucial to regulate ECM 
proteolysis, which is important in metastasis. This study examined the effects 
of 3 flavonoid-enriched fractions (a crude fraction, an anthocyanin-enriched 
fraction, and a proanthocyanidin-enriched fraction), which were prepared from 
lowbush blueberries (Vaccinium angustifolium), on MMP activity in DU145 human 
prostate cancer cells in vitro. Using gelatin gel electrophoresis, MMP activity 
was evaluated from cells after 24-hr exposure to blueberry fractions. All 
fractions elicited an ability to decrease the activity of MMP-2 and MMP-9. Of 
the fractions tested, the proanthocyanidin-enriched fraction was found to be the 
most effective at inhibiting MMP activity in these cells. No induction of either 
necrotic or apoptotic cell death was noted in these cells in response to 
treatment with the blueberry fractions. These findings indicate that flavonoids 
from blueberry possess the ability to effectively decrease MMP activity, which 
may decrease overall ECM degradation. This ability may be important in 
controlling tumor metastasis formation.PMID: 16234852 [PubMed - indexed for MEDLINE]Phenolic compounds from blueberries can inhibit colon cancer 
cell proliferation and induce apoptosis.J Agric Food Chem. 2005 Sep 7;53(18):7320-9Department of Food Science and Technology, The University of 
Georgia, Athens, Georgia 30602-7610, USA.Research has shown that diets rich in phenolic compounds may be 
associated with lower risks of several chronic diseases including cancer. This 
study systematically evaluated the bioactivities of phenolic compounds in 
rabbiteye blueberries and assessed their potential antiproliferation and 
apoptosis induction effects using two colon cancer cell lines, HT-29 and Caco-2. 
Polyphenols in three blueberry cultivars, Briteblue, Tifblue, and Powderblue, 
were extracted and freeze-dried. The extracts were further separated into 
phenolic acids, tannins, flavonols, and anthocyanins using an HLB cartridge and 
LH20 column. Some individual phenolic acids and flavonoids were identified by 
HPLC with >90% purity in anthocyanin fractions. The dried extracts and 
fractions were added to the cell culture medium to test for antiproliferation 
activities and induction of apoptosis. Flavonol and tannin fractions resulted in 
50% inhibition of cell proliferation at concentrations of 70-100 and 50-100 
microg/mL in HT-29 and Caco-2 cells, respectively. The phenolic acid fraction 
showed relatively lower bioactivities with 50% inhibition at approximately 1000 
microg/mL. The greatest antiproliferation effect among all four fractions was 
from the anthocyanin fractions. Both HT-29 and Caco-2 cell growth was 
significantly inhibited by >50% by the anthocyanin fractions at 
concentrations of 15-50 microg/mL. Anthocyanin fractions also resulted in 2-7 
times increases in DNA fragmentation, indicating the induction of apoptosis. The 
effective dosage levels are close to the reported range of anthocyanin 
concentrations in rat plasma. These findings suggest that blueberry intake may 
reduce colon cancer risk.
| Blueberryextract |  
| 
 |  
| Stroke and BlueberryA study published in the May 2005 issue of the Journal of 
Experimental Neurology tested the effects of blueberry to lessen the 
consequences of stroke. Researchers fed three groups of rats chow that was 
enriched with either blueberries, spirulina, spinach. A fourth group was fed 
unenriched food. After four weeks an ischemic stroke with reperfusion was 
introduced to the rats. In the blueberry fed rats the size of the area of the 
brain damaged by the stroke was half that of the control group (Wang Y, Chang 
CF, Chou J, Chen HL, Deng X, Harvey BK, Cadet JL, Bickford PC. Dietary 
supplementation with blueberries, spinach, or spirulina reduces ischemic brain 
damage. Exp Neurol. 2005 May;193(1):75-84).Clinical AbstractsDietary supplementation with blueberries, spinach, or 
spirulina reduces ischemic brain damage.Exp Neurol. 2005 May;193(1):75-84National Institute on Drug Abuse, Intramural Research Program, 
Baltimore, MD 21224, USA.Free radicals are involved in neurodegenerative disorders, such 
as ischemia and aging. We have previously demonstrated that treatment with diets 
enriched with blueberry, spinach, or spirulina have been shown to reduce 
neurodegenerative changes in aged animals. The purpose of this study was to 
determine if these diets have neuroprotective effects in focal ischemic brain. 
Adult male Sprague-Dawley rats were fed with equal amounts of diets (blueberry, 
spinach, and spirulina) or with control diet. After 4 weeks of feeding, all 
animals were anesthetized with chloral hydrate. The right middle cerebral artery 
was ligated with a 10-O suture for 60 min. The ligature was later removed to 
allow reperfusional injury. Animals were sacrificed and brains were removed for 
caspase-3 enzymatic assays and triphenyltetrazolium chloride staining at 8 and 
48 h after the onset of reperfusion. A subgroup of animals was used for 
locomotor behavior and biochemical assays. We found that animals which received 
blueberry, spinach, or spirulina enriched diets had a significant reduction in 
the volume of infarction in the cerebral cortex and an increase in post-stroke 
locomotor activity. There was no difference in blood biochemistry, blood CO2, 
and electrolyte levels among all groups, suggesting that the protection was not 
indirectly mediated through the changes in physiological functions. Animals 
treated with blueberry, spinach, or spirulina had significantly lower caspase-3 
activity in the ischemic hemisphere. In conclusion, our data suggest that 
chronic treatment with blueberry, spinach, or spirulina reduces 
ischemia/reperfusion-induced apoptosis and cerebral infarction.PMID: 15817266 [PubMed - indexed for MEDLINE]Blueberry- and spirulina-enriched diets enhance striatal 
dopamine recovery and induce a rapid, transient microglia activation after 
injury of the rat nigrostriatal dopamine system.Exp Neurol. 2005 Dec;196(2):298-307. Epub 2005 Sep 19Department of Integrative Medical Biology, Umea University, S 
901 87 Umea, Sweden. ingrid.stromberg@histocel.umu.seNeuroinflammation plays a critical role in loss of dopamine 
neurons during brain injury and in neurodegenerative diseases. Diets enriched in 
foods with antioxidant and anti-inflammatory actions may modulate this 
neuroinflammation. The model of 6-hydroxydopamine (6-OHDA) injected into the 
dorsal striatum of normal rats, causes a progressive loss of dopamine neurons in 
the ventral mesencephalon. In this study, we have investigated the inflammatory 
response following 6-OHDA injected into the striatum of adult rats treated with 
diet enriched in blueberry or spirulina. One week after the dopamine lesion, a 
similar size of dopamine degeneration was found in the striatum and in the 
globus pallidus in all lesioned animals. At 1 week, a significant increase in 
OX-6- (MHC class II) positive microglia was found in animals fed with blueberry- 
and spirulina-enriched diets in both the striatum and the globus pallidus. These 
OX-6-positive cells were located within the area of tyrosine hydroxylase (TH) 
-negativity. At 1 month after the lesion, the number of OX-6-positive cells was 
reduced in diet-treated animals while a significant increase beyond that 
observed at 1 week was now present in lesioned control animals. Dopamine 
recovery as revealed by TH-immunohistochemistry was significantly enhanced at 4 
weeks postlesion in the striatum while in the globus pallidus the density of 
TH-positive nerve fibers was not different from control-fed lesioned animals. In 
conclusion, enhanced striatal dopamine recovery appeared in animals treated with 
diet enriched in antioxidants and anti-inflammatory phytochemicals and coincided 
with an early, transient increase in OX-6-positive microglia.PMID: 16176814 [PubMed - indexed for MEDLINE] |  PMID: 16131149 [PubMed - indexed for MEDLINE |